146 related articles for article (PubMed ID: 6204463)
1. [Surgical therapy of metastasizing kidney cancer. A retrospective study].
Flamm J
Wien Med Wochenschr; 1984 Apr; 134(7):147-51. PubMed ID: 6204463
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of metastasizing kidney cancer with hormones (androgens). A retrospective study].
Flamm J
Z Urol Nephrol; 1983 Jun; 76(6):407-11. PubMed ID: 6637169
[TBL] [Abstract][Full Text] [Related]
3. [Status of surgery in the treatment of metastatic renal cell carcinoma].
Flamm J; Wöber L
Wien Klin Wochenschr; 1987 Dec; 99(24):838-42. PubMed ID: 2449767
[TBL] [Abstract][Full Text] [Related]
4. Results of radical nephrectomy in 178 cases of renal cell adenocarcinoma.
Oliver JA; Laplante MP; Reid EC; Schual RS
Can J Surg; 1979 Sep; 22(5):409-12. PubMed ID: 497907
[TBL] [Abstract][Full Text] [Related]
5. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
[TBL] [Abstract][Full Text] [Related]
7. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
[TBL] [Abstract][Full Text] [Related]
8. Clinical study of patients with renal carcinoma surviving for more than 10 years after nephrectomy.
Onishi T; Machida T; Masuda F; Iizuka N; Shirakawa H; Hatano T
Br J Urol; 1992 Nov; 70(5):483-7. PubMed ID: 1467849
[TBL] [Abstract][Full Text] [Related]
9. Operative mortality after nephrectomy for renal cell carcinoma.
Thoroddsen A; Gudbjartsson T; Jonsson E; Gislason T; Einarsson GV
Scand J Urol Nephrol; 2003; 37(6):507-11. PubMed ID: 14675926
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant autologous tumour cell-lysate vaccine versus no adjuvant treatment in patients with M0 renal cell carcinoma after radical nephrectomy: 3-year interim analysis of a German multicentre phase-III trial.
Doehn Ch; Richter A; Lehmacher W; Jocham D
Folia Biol (Praha); 2003; 49(2):69-73. PubMed ID: 12779015
[TBL] [Abstract][Full Text] [Related]
11. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
12. [Cancer of the kidney. Natural history and therapeutic problems].
Paolucci R; Delledonne V; Balaban C; Zola C; Bilardi G
Minerva Chir; 1981 May; 36(10):671-8. PubMed ID: 7254544
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
[TBL] [Abstract][Full Text] [Related]
14. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients].
Chen XF; Zhou FJ; Han H; Qin ZK; Liu ZW; Yu SL; Li YH; Wang H; Hou GL
Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946
[TBL] [Abstract][Full Text] [Related]
15. [Local recurrence of renal cell carcinoma after nephrectomy].
Pereverzev AS; Shchukin DV; Iliukhin IuA
Urologiia; 2003; (6):14-8. PubMed ID: 14708237
[TBL] [Abstract][Full Text] [Related]
16. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.
Schrodter S; Hakenberg OW; Manseck A; Leike S; Wirth MP
J Urol; 2002 Apr; 167(4):1630-3. PubMed ID: 11912377
[TBL] [Abstract][Full Text] [Related]
17. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
18. Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival.
Bruno JJ; Snyder ME; Motzer RJ; Russo P
BJU Int; 2006 May; 97(5):933-8. PubMed ID: 16643473
[TBL] [Abstract][Full Text] [Related]
19. [The surgical therapy of renal carcinomas. The prognostic factors and long-term results].
Scilletta B; Di Carlo I; Lombardo R; Aronica G; Di Stefano F; Racalbuto A; Puleo S
Minerva Chir; 1999 Mar; 54(3):157-62. PubMed ID: 10352525
[TBL] [Abstract][Full Text] [Related]
20. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
